Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza
Not Applicable
- Conditions
- InfluenzaD007251
- Registration Number
- JPRN-jRCT1051180014
- Lead Sponsor
- Kato Kentaro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1)axillary temperature more than 37.5 degree
2)a positive rapid antigen test for influenza virus
3)a symptom duraiton of no more than 36 hours
4)hospitalized patient
5)body weight more than 10kg
Exclusion Criteria
1)patients who have suffered from bacterial infection or other viral infection within one week from the start of the study
2)patients who received recipes of Baloxavir marboxil, Oseltamivir, Zanavivir, Laninavir, Peramivir within 4 weeks from the start of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time to alleviation of influenza symptoms <br>The time to resolution of fever
- Secondary Outcome Measures
Name Time Method The changes from baseline in infectious virus and viral RNA titers